Phase Ii study of 5-day infusion of vinblastine in patients with advanced ovarian carcinoma
Shah, M.K.; St Marie, K.; Catalano, R.B.; Dierks, K.; Creech, R.H.
Cancer Treatment Reports 69(2): 229-230
1985
ISSN/ISBN: 0361-5960 PMID: 3882232 Document Number: 264238
Document emailed within 1 workday
Related Documents
Takezako, Y.; Okusaka, T.; Ueno, H.; Ikeda, M.; Morizane, C.; Najima, M. 2008: Phase Ii study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC) Hepato-Gastroenterology 55(85): 1380-1384Kavanagh, J.J.; Wharton, J.T.; Rutledge, F.N. 1984: Continuous-infusion vinblastine for treatment of refractory epithelial carcinoma of the ovary: a phase Ii trial Cancer Treatment Reports 68(11): 1417-1418
Benson, A.B.; Trump, D.L.; Koeller, J.M.; Egorin, M.I.; Olman, E.A.; Witte, R.S.; Davis, T.E.; Tormey, D.C. 1985: Phase i study of vinblastine and verapamil given by concurrent iv infusion Cancer Treatment Reports 69(7-8): 795-799
Scotto, V.; Sbiroli, C. 1991: Weekly cis-platinum as third line chemotherapy in advanced ovarian carcinoma. Phase Ii study European Journal of Gynaecological Oncology 12(1): 51-53
Pujade-Lauraine, E.; Guastalla, J.P.; Weber, B.; Curé, H.; Orfeuvre, H.; Mousseau, M.; Vincent, P.; Diéras, V.; Tubiana-Mathieu, N.; Jacquin, J.P.; Mignot, L.; Leduc, B.; Paraïso, D.; Viens, P. 1997: Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase Ii study Seminars in Oncology 24(5 Suppl 15: S15
Sörenson, S.; Hansen, H.H.; Dombernowsky, P. 1976: Phase Ii study of vinblastine, adriamycin, and procarbazine in small cell carcinoma of the lung Cancer Treatment Reports 60(9): 1263-1266
Vardi, J.R.; Tadros, G.H.; Zamurovic, D.; Rafla, S.D. 1992: Tumor debulking followed by immediate combination chemotherapy in advanced ovarian carcinoma. Phase II Acta Obstetricia et Gynecologica Scandinavica 71(5): 361-367
Dexeus, F.; Logothetis, C.J.; Samuels, M.L.; Hossan, E.; von Eschenbach, A.C. 1985: Continuous infusion of vinblastine for advanced hormone-refractory prostate cancer Cancer Treatment Reports 69(7-8): 885-886
Kunisaki, C.; Imada, T.; Yamada, R.; Hatori, S.; Ono, H.; Otsuka, Y.; Matsuda, G.; Nomura, M.; Akiyama, H.; Kubo, A.; Shimada, H. 2005: Phase II study of docetaxel plus cisplatin as a second-line combined therapy in patients with advanced gastric carcinoma Anticancer Research 25(4): 2973-2977
Cowan, J.D.; Surwit, E.A.; Alberts, D.S.; Boutselis, J.G.; Neilan, B.A. 1986: Phase II trial of bisantrene in previously treated patients with ovarian carcinoma: a Southwest Oncology Group Study Cancer Treatment Reports 70(3): 423-424
Tropé, C.; Mattsson, W.; Gynning, I.; Johnsson, J.E.; Sigurdsson, K.; Orbert, B. 1981: Phase Ii study of spirogermanium in advanced ovarian malignancy Cancer Treatment Reports 65(1-2): 119-120
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Smith, D.B.; Thatcher, N.; Steward, W.P.; Brear, G.; Carroll, K.B. 1986: A phase II study of cyclophosphamide as a 24-hr infusion in advanced non-small cell lung cancer European Journal of Cancer and Clinical Oncology 22(4): 435-437
Vicini, D.; Franceschetti, G.P.; Mirando, P.; Ruggieri, M.; Cardellini, P. 1993: Interferon and vinblastine in advanced renal carcinoma Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 65(2): 181-184
Thongprasert, S.; Chewaskulyong, B. 2004: Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer Journal of the Medical Association of Thailand 87(10): 1162-1167
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Rosenthal, D.I.; Sinard, R.J.; Okani, O.; Corak, J.; Kavanaugh, D.; Kamen, B.; Vuitch, F.M.; Gazdar, A.F.; Griener, J.; Frenkel, E.P.; Carbone, D.P. 1997: Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase i study Seminars in Oncology 24(6 Suppl 19: S19
Hakes, T.B.; Raymond, V. 1987: Phase Ii study of idarubicin in advanced endometrial carcinoma Cancer Treatment Reports 71(5): 535-536
Slavik, M.; Muss, H.; Blessing, J.A.; Delgado, G. 1982: Phase Ii clinical study of Yoshi 864 in epithelial ovarian carcinoma: a Gynecologic Oncology Group Study Cancer Treatment Reports 66(9): 1775-1777
Tauer, K.; Kemeny, N.; Cheng, E.; Hollander, P.; Geller, N. 1986: Phase Ii trial of N-methylformamide in patients with advanced colorectal carcinoma Cancer Treatment Reports 70(6): 813-814